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Background: Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominantly inherited disorder caused by
germline mutations in the folliculin (FLCN) gene. Clinical manifestations of BHD include skin fibrofolliculomas, renal
cell cancer, lung cysts and (recurrent) spontaneous pneumothorax (SP). All clinical manifestations usually present in
adults > 20 years of age.
Case presentations: Two non-related patients with (recurrent) pneumothorax starting at age 14 accompanied by
multiple basal lung cysts on thoracic CT underwent FLCN germline mutation analysis. A pathogenic FLCN mutation
was found in both patients confirming suspected BHD. The family history was negative for spontaneous pneumothorax
in both families.
Conclusion: Although childhood occurrence of SP in BHD is rare, these two cases illustrate that BHD should be
considered as cause of SP in children.
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FibrofolliculomasBackground
Birt-Hogg-Dubé syndrome (BHD) is a rare tumour pre-
disposition syndrome first described in 1977 [1]. The
syndrome is characterized by skin fibrofolliculomas, lung
cysts, (recurrent) spontaneous pneumothorax (SP) and
renal cell cancer. The underlying cause is a germline mu-
tation in the folliculin (FLCN) gene located on chromo-
some 17p11.2. Clinical manifestation usually appears after
the age of 20 years. We here present two cases of BHD
with episodes of recurrent pneumothorax of which the
first episode occurred at the age of 14 years.Case presentation
Case 1
A 14-year-old Caucasian boy, without any medical prob-
lems in the past, non-smoker, was admitted to the Emer-
gency Department due to shortness of breath and right-* Correspondence: pe.postmus@vumc.nl
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article, unless otherwise stated.sided chest pain which increased when bending over. In
general, he looked healthy and he had no fever. Breath
sounds over the right hemithorax were reduced. Routine
laboratory tests showed no abnormalities. Chest X-ray
showed a right-sided pneumothorax with a complete col-
lapse of the right lung. After drainage by catheter, thora-
coscopic pleurodesis was performed. Approximately 8
months later right-sided pneumothorax recurred and was
treated by partial right-sided pleurectomy. In the subse-
quent two years the patient had another two recurrences,
both treated by catheter drainage. Because of the recurrent
episodes of pneumothorax a CT of his chest was per-
formed, which showed multiple cysts below the level of the
carina in the lung parenchyma adjacent to the visceral
pleura (subpleurally), predominantly on the right side.
(CT-thorax, Figure 1a and b) BHD was suspected and gen-
etic testing confirmed a pathogenic splice-site mutation in
the gene (c.1177-5_1177-3delCTC). Skin fibrofolliculomas
and renal abnormalities were absent in this patient. Subse-
quently other family members were counselled by the clin-
ical geneticist. Three family members were also affected.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Thoracic CT of case 1. a. CT shows a pneumothorax with
a intraparenchymal located cyst with small septa. b. Shows multiple
cysts in the lower lobes (under the carina), in the same patient after
treatment of the pneumothorax.
Figure 2 Thoracic CT of case 2. a. CT image of pneumothorax
with a cluster of lung cysts in the right lower lobe. b. Shows a lung
cyst located subpleurally in the right lower lobe, abutting the main
fissure as shown after resolving of the pneumothorax.
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or (recurrent) episodes of pneumothorax.
Case 2
A 19-year-old Caucasian male presented at the Emergency
Department due to recurrent right-sided pneumothorax.
The first episode had occurred at age 14 and was treated
by video-assisted-thoracoscopic surgery (VATS). A chest
CT now revealed a completely collapsed right lung
with multiple air-filled structures described as bullae
at the ventro-cranial side of the right lower lobe. Anuncomplicated VATS procedure was performed. Although
the thoracic CT showed multiple cysts mainly in the basal
parts of the right lung, none were seen at operation. Total
pleurectomy was performed. Two years later the patient
was referred to our center for evaluation for BHD as this
syndrome had been diagnosed in several family members.
A chest CT now showed several small cysts in both lungs
in the parenchyma and larger cysts resembling ‘bullae’
mainly in the right lung (CT-thorax, Figure 2a and b).
Genetic testing confirmed a pathogenic splice-site mu-
tation (c.1301-7_1304del;1323delCinsGA) of the FLCN
gene., which confirmed the diagnosis of BHD. Skin
fibrofolliculomas and renal abnormalities were absent in
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but no RCC or pneumothorax had been observed.
Conclusions
We report here two paediatric patients with recurrent
spontaneous pneumothorax as a manifestation of the
Birt-Hogg-Dubé syndrome (BHD). Lung cysts were seen
in both patients, predominantly located below the level
of the carina, located subpleurally in the lung paren-
chyma. The location of these cysts is typical for BHD.
In general, the incidence of paediatric primary and sec-
ondary SP is approximately 4 per 100.000 males and 1.1.
per 100.000 females per year, which is much less common
than in adulthood [2,3]. The mean age at presentation of
PSP in paediatric cases is between 13.8-15.9 years and oc-
curs commonly in tall, thin males [4]. A specific racial/
ethnic predominance has not been described in literature
[2]. The underlying cause in spontaneous SP in adulthood
is often unknown in the primary form, but secondary SP
may be due to an inflammatory or connective tissue
disease, infection, malignancy, foreign body aspiration or
congenital malformation [5]. Subpleural bullae, mainly in
the apex of the lung, are found in 76-100 per cent of adult
PSP patients during VATS and thoracotomy [6]. Among
non-smokers with a history of PSP, 81 per cent have bullae
[7]. The general underlying mechanism of PSP in child-
hood seems to be connective tissue changes, which pre-
dispose to spontaneous leaking of air from the airways
into the pleural space. Several case series suggest a rela-
tion between subpleural blebs/bullae and the occurrence
of SP [2,8]. The incidence of blebs and bullae detected
on CT in children with SP is between 45% and 100% [9].
The clinical significance of these blebs and bullae re-
mains unclear [4].
SP in children is often diagnosed based on medical his-
tory and physical examination, confirmed by chest radiog-
raphy. The additional value of chest CT is unclear. In the
British Thoracic Society (BTS) guidelines a CT of the
chest is indicated when chest radiography is negative of
clinical signs for SP or for determining appropriate man-
agement strategies. Because blebs, bullae and cysts are
only visible on CT, which is performed in a minority of
cases, the diagnosis BHD is likely to be missed.
Adult literature reports a recurrence rate in primary
SP of approximately 30 percent, with a range of 16 to 52
percent [10]. In children a recurrence rate up to 61 per-
cent has been reported and seems to be higher compared
to the adult data [11]. A smaller study by Ouanes-Berbes
et al. reported a 19% overall recurrence rate over 7 year
follow-up in a young adult cohort, with a 72 percent inci-
dence of bullae [12].
In adults, multiple lung cysts are associated with
Birt-Hogg-Dubé syndrome, with a basal rather than ap-
ical distribution. The literature on the incidence of BHDsyndrome in adults with PSP is very limited. Ren and
colleagues found a prevalence of 9.8% in 102 apparently
adult SP patients [13]. In a pilot study among 40 appar-
ently primary SP patients we found a pathogenic FLCN
mutation in 3 (7.5%) patients [14].
Previously, SP has been reported twice in paediatric
BHD patients both confirmed by the demonstration of a
pathogenic FLCN-mutation. The first patient had one epi-
sode of SP at age of 7 years. Chest CT was not performed.
The second patient at age of 16 years, with a positive
family history for SP, had in total 6 episodes of SP on
both sides with, multiple basally located cysts on chest
CT [15,16]. The youngest BHD patient with pneumo-
thorax we observed was an 18 year old woman with two
episodes of right sided spontaneous pneumothorax with
lung cysts [17].
BHD [OMIM no. 135150] is a rare autosomal dominant
inherited disorder caused by germline mutations in the
(FLCN) gene located on chromosome 17p11.2. The BHD
gene encodes for the protein folliculin which is expressed
in skin, kidney and nephrons and type 1 pulmonary alveo-
lar epithelial cells. The function of folliculin has not been
fully clarified [18,19]. Clinically BHD is characterized by
skin fibrofolliculomas, a 50-fold increased risk for develop-
ment of (recurrent) SP, multiple lung cysts predominantly
in the basal parts of the lung, renal cysts and renal cancer
from the age of 20 [17,18]. Patients are advised to undergo
lifelong surveillance, preferably by periodic renal MRI or
ultrasound. Because the clinical expression can vary and is
age-dependent, BHD syndrome in patients who present
with pneumothorax cannot be excluded when no renal ab-
normalities or skin lesions are found [20]. The differential
diagnosis of patients with multiple lung cysts include
emphysema, cystic bronchiectasis, honeycomb change,
cavitated infective nodules, pulmonary Langerhans cell
histiocytosis (LCH), lymphangioleiomyomatosis (LAM),
lymphocytic interstitial pneumonia (LIP), follicular bron-
chiolitis, amyloidosis, light chain deposition disease (LCDD)
and Birt-Hogg-Dubé (BHD) syndrome [21]. The cystic pat-
tern in BHD differs from that observed in other lung
diseases; In BHD multiple thin-walled pulmonary cysts of
various sizes are observed, predominately distributed to the
lower medial and subpleural regions of the lung with cysts
abutting or including the proximal portion of the lower
pulmonary veins or arteries [22-24].
Treatment of SP in children does not differ from that
in adults and depends on size and underlying cause. Both
BTS and American College of Chest Physicians (ACCP)
have published different recommendations for treatment
of primary SP in adults as well paediatric patients. Mul-
tiple studies in adult literature advocate aspiration as a
first treatment option in PSP. For secondary SP or recur-
rent SP the ACCP and BTS recommend tube thoracost-
omy and surgical recurrence prevention [2,25]. Whether
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be more aggressive than in idiopathic SP is still under
debate [18].
In conclusion we report here two cases of Birt-Hogg-
Dubé syndrome in children with recurrent pneumothorax.
As SP in the paediatric population is relatively rare, BHD
should be considered as underlying cause, especially when
there is a positive family history for pneumothorax, skin
fibrofolliculomas or renal cell cancer. BHD patients are at
increased risk for renal cell cancer and therefore diagnosis
is important for the affected children and their family
members. Therefore we suggest that a thorough family
history, low dose chest CT (with the restraints of using
CT scans in the paediatric population) and easy accessible
genetic testing for BHD are important options for paediat-
ric patients with (recurrent) SP should be performed, even
when skin manifestation are absent. We also suggest more
research is needed on the prevalence of BHD in the
pediatric population with a history of (recurrent) SP.
Consent
Written informed consent was obtained from both pa-
tients for publication of this Case report and any accom-
panying images. Both patients were over the age of 18
when the manuscript was submitted to this journal.
Ethics
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As SP in the paediatric population is relatively rare, BHD
should be considered as underlying cause, especially when
there is a positive family history for pneumothorax, skin
fibrofolliculomas or renal cell cancer. BHD patients are at
increased risk for renal cell cancer and therefore diagnosis
is important for the affected children and their family
members. Therefore we suggest that a thorough family
history, low dose chest CT (with the restraints of using
CT scans in the paediatric population) and easy accessible
genetic testing for BHD are important options for paediat-
ric patients with (recurrent) SP should be performed, even
when skin manifestation are absent. We also suggest more
research is needed on the prevalence of BHD in the
pediatric population with a history of (recurrent) SP.
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